BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1573857)

  • 1. Presence of growth factors in human pituitary.
    Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
    Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
    Riss TL; Sirbasku DA
    J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of transforming growth factors by human colon cancer lines.
    Coffey RJ; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
    Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
    J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
    Sanfilippo JS; Rao CV; Guarnaschelli JJ; Woost PG; Byrd VM; Jones E; Schultz GS
    Surg Gynecol Obstet; 1993 Nov; 177(5):488-96. PubMed ID: 8211601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.
    Humes HD; Beals TF; Cieslinski DA; Sanchez IO; Page TP
    Lab Invest; 1991 Apr; 64(4):538-45. PubMed ID: 2016859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H; Chen JK
    J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
    Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
    J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor production by human colon carcinoma cell lines.
    Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
    Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors.
    Halper J; Carter BJ
    J Cell Physiol; 1989 Oct; 141(1):16-23. PubMed ID: 2777898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A transforming growth factor-beta like growth factor in mouse embryonal carcinoma cells].
    Shi WK; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1989 Jun; 22(2):213-23. PubMed ID: 2800839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
    Santa-Olalla J; Covarrubias L
    J Neurosci Res; 1995 Oct; 42(2):172-83. PubMed ID: 8568917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
    Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.